Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000102909-25-000324·SOLENO THERAPEUTICS INC
Schedule 13G ownership disclosure
Soleno Therapeutics Inc
Common Stock · CUSIP: 834203309
Event date: 2025-09-30
- Filing-level shares
- 2,807,149
- Percent of class
- 5.28%
- The Vanguard Group
Shares: 2,807,149 · Class: 5.28%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000102909-25-000324
- Form type
- SCHEDULE 13G
- Filer
- SOLENO THERAPEUTICS INC
- CIK
- CIK 1484565
- Filed
- Oct 31, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership